Skip to main content
BMC Cancer logoLink to BMC Cancer
. 2026 Jul 26;26:899. doi: 10.1186/s12885-026-16503-3

Editorial expression of concern: NMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma (HCC) cells, and inhibits growth and vascularization in vivo

Christian Moser 1, Sven A Lang 1, Akira Mori 1, Claus Hellerbrand 2, Hans J Schlitt 1, Edward K Geissler 1, William E Fogler 3, Oliver Stoeltzing 1,
PMCID: PMC13401779  PMID: 42503506

Editorial expression of concern: Mol Cancer Ther 6, 2868 (2007)

https://doi.org/10.1186/1471-2407-8-206

The Editor would like to alert the readers that concerns have been raised about a possible image similarity detected across two publications from the same authors. Specifically, Fig. 2A β-actin (HUH7) of this paper appears to be a vertical flip of the Fig. 1B, β-Actin bands (HCT116) in [1].

Readers are therefore advised to interpret these results with caution.

None of the Authors responded to correspondence from the Publisher about this Editorial Expression of Concern.

Reference

  • 1.Moser C, Lang SA, Kainz S, Gaumann A, Fichtner-Feigl S, Koehl GE, … Stoeltzing O. Blocking heat shock protein-90 inhibits the invasive properties and hepatic growth of human colon cancer cells and improves the efficacy of oxaliplatin in p53-deficient colon cancer tumors in vivo. Mol Cancer Ther. 2007;6(11):2868–78. [DOI] [PubMed] [Google Scholar]

Articles from BMC Cancer are provided here courtesy of BMC

RESOURCES